Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) as a generic product under NorthStar Rx LLC's ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAROXETINE HYDROCHLORIDE (Paroxetine hydrochloride)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE HYDROCHLORIDE)